NK-92® Cell Based Bioanalytical Solutions are the Key to Optimizing R&D and Commercial Product Development Efforts for Monoclonal Antibodies, Bi-Specifics and Related Biological Products SAN DIEGO–Brink Biologics, Inc., a NantKwest, Inc. (Nasdaq:NK) affiliate who serves as exclusively-licensed distributor of NantKwest’s proprietary NK-92® natural killer cells, offers a variety of research grade aNK™ and haNK® cell lines for […]
SHERBROOKE WELCOMES THE FIRST WATERS CENTRE OF INNOVATION IN CANADA SHERBROOKE, QC – Waters Corporation inaugurates the first ever Centre of Innovation for Mass Spectrometry in Canada here in Sherbrooke. The research will focus on applying and transferring knowledge to clinical practice and aims to improve the diagnosis of rare genetic diseases, leading to personalized patient follow-up. Several hundred people are expected […]
Amendment allows for the development of IVD test kits compatible with Illumina technology TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has amended its IVD Test Developmentand Component Supply Agreement with Illumina, Inc. (Illumina), previously amended in June 2017, to enable the expansion of potential fields for […]
(Boston, MA and Munich, Germany) – Invicro LLC, a Konica Minolta company and iTheraMedical GmbH announced a unique partnership with the placement of the MSOT inVision platform in Invicro’s in vivo laboratory out of its Boston headquarters. Both companies will come together to uniquely offer Pharmaceutical, Biotech and Academia sponsors services from the optoacoustic platform that will identify […]
The Global Health Drug Discovery Institute (GHDDI) Licenses Scilligence ELN The Global Health Drug Discovery Institute (GHDDI) has licensed Scilligence Electronic Laboratory Notebook (ELN). Scilligence ELN will help GHDDI to strength collaboration within the organization by digitalizing experimental data. GHDDI researchers are now able to easily search and organize their experiments and associated files. About The […]
Use of Agilent’s custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics and accelerated pharmaceutical development SANTA CLARA, Calif., & BOULDER, Colo. Agilent Technologies Inc. (NYSE: A) and SomaLogic, Inc. (a privately held biotechnology company) today announced a multi-year supply agreement whereby Agilent will supply customized high-fidelity oligo microarrays for […]
CLEVELAND, OH – Ohio Lumex, a global leader in environmental and process monitoring, has been awarded exclusive distribution rights of G.A.S. GC-IMS products in the U.S. and Canada. G.A.S., based in Dortmund, Germany, develops custom instruments that detect and quantify hazardous or unwanted compounds at low ppb-level in air or gases. They use a unique two-stage separation technique […]
In 2017 Stellenbosch University, South Africa undertook an experimental campaign which focused on analysing venomous snake fangs. The motivation behind the campaign was to understand in detail the internal and external morphology and mechanical properties of snake fangs. The study focused on comparing the maximum Von Mises stress values when a load was applied to […]
Strategic collaboration between two organisations represents largest nanopore sequencing project to date, capitalising on recent developments bringing ultra-high yields with PromethION GrandOmics, a leading sequencing company in China, has announced a populational-scale project, dbSV100k, to understand the impact of structural variation on human disease. The project aims to sequence 20,000 human genomes in 2019, with […]
Nanjing, China · Camarillo, California, US —— GenScript Biotech Corporation, a world leading bio-pharmaceutical CDMO company, has entered into an exclusive strategic drug development cooperation with REMD Biotherapeutics Inc. (hereinafter REMD) on several bispecific antibodies. According to the Agreement, GenScript will allow REMD to use its SMAB (Single-Domain Antibody fused to Monoclonal Ab) Platform, a bispecific […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
